chr10-74843012-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP2PP3

The NM_012330.4(KAT6B):​c.155A>C​(p.Glu52Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

KAT6B
NM_012330.4 missense

Scores

8
8
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.95
Variant links:
Genes affected
KAT6B (HGNC:17582): (lysine acetyltransferase 6B) The protein encoded by this gene is a histone acetyltransferase and component of the MOZ/MORF protein complex. In addition to its acetyltransferase activity, the encoded protein has transcriptional activation activity in its N-terminal end and transcriptional repression activity in its C-terminal end. This protein is necessary for RUNX2-dependent transcriptional activation and could be involved in brain development. Mutations have been found in patients with genitopatellar syndrome. A translocation of this gene and the CREBBP gene results in acute myeloid leukemias. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), KAT6B. . Gene score misZ 2.8874 (greater than the threshold 3.09). Trascript score misZ 4.8748 (greater than threshold 3.09). GenCC has associacion of gene with RASopathy, genitopatellar syndrome, KAT6B-related multiple congenital anomalies syndrome, blepharophimosis - intellectual disability syndrome, SBBYS type.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.823

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KAT6BNM_012330.4 linkuse as main transcriptc.155A>C p.Glu52Ala missense_variant 3/18 ENST00000287239.10 NP_036462.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KAT6BENST00000287239.10 linkuse as main transcriptc.155A>C p.Glu52Ala missense_variant 3/181 NM_012330.4 ENSP00000287239 P2Q8WYB5-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxOct 13, 2023Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Pathogenic
0.32
D
BayesDel_noAF
Pathogenic
0.22
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.71
D;.;.;D;.;.;.;.;.;.;.;.;.;.;.;D;.;.;.;.;.;.;.;.
Eigen
Pathogenic
0.72
Eigen_PC
Pathogenic
0.76
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Uncertain
0.12
D
MetaRNN
Pathogenic
0.82
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.33
D
MutationAssessor
Uncertain
2.9
M;.;M;M;M;.;.;.;.;.;M;.;M;.;M;M;.;.;.;.;.;.;M;.
MutationTaster
Benign
0.52
D;D;D;D;D
PrimateAI
Uncertain
0.75
T
PROVEAN
Pathogenic
-5.2
.;.;.;.;D;.;.;.;.;.;.;.;D;.;D;D;.;.;.;.;.;.;D;.
REVEL
Pathogenic
0.68
Sift
Uncertain
0.0020
.;.;.;.;D;.;.;.;.;.;.;.;D;.;D;D;.;.;.;.;.;.;D;.
Sift4G
Uncertain
0.0040
.;.;.;.;D;.;.;.;.;.;.;.;D;.;D;D;.;.;.;.;.;.;D;.
Polyphen
0.91
P;.;P;P;P;.;.;.;.;.;P;.;P;.;P;P;.;.;.;.;.;.;P;.
Vest4
0.71, 0.69, 0.67, 0.72, 0.68
MutPred
0.39
Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);Loss of disorder (P = 0.1232);
MVP
0.78
MPC
0.68
ClinPred
0.99
D
GERP RS
6.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.68
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr10-76602770; API